Table 4.
Protein name | Gene symbol | Phosphosite | WT:RKO ratios |
---|---|---|---|
Abhydrolase domain-containing protein 15 | Abhd15 | T142 | 9, >100, >100 |
α-1B adrenergic receptor | Adra1b | S266 | >100, >100, >100 |
Atpase, class VI, type 11C | Atp11c | S1113 | 5, 4, 32 |
Protein dopey-2 | Dopey2 | S718 | >100, 26, 31 |
Phospholemman | Fxyd1 | S82 | 9, 11, 7 |
Phospholemman | Fxyd1 | S83 | 8, >100, 9 |
Phospholemman | Fxyd1 | T79 | 9, 11, 7 |
GC-rich sequence DNA-binding factor 1 | Gcfc | S262 | >100, >100, 10, |
Glucagon receptor | Gcgr | S432 | >100, >100, >100 |
Glycogen [starch] synthase, liver | Gys2 | S645, S652 | >100, 59, >100 |
HIV Tat-specific factor 1 homolog | Htatsf1 | S441, S446 | >100, >100, >100 |
Insulin receptor | Insr | S1340 | 34, 10, 7 |
N-myc downstream regulated 2 | Ndrg2 | S328, T330, S332, T334 | 11, 19, 51 |
N-myc downstream regulated 2 | Ndrg2 | S335, S338 | 7, 9, 10 |
N-myc downstream regulated 2 | Ndrg2 | S346, S350, S353 | 5, 7, 8 |
N-myc downstream regulated 2 | Ndrg2 | S346, S353 | 4, 6, 6 |
N-myc downstream regulated 2 | Ndrg2 | S346, T348, S353 | >100, 7, 30 |
N-myc downstream regulated 2 | Ndrg2 | S352, S353, S355 | 4, 4, 6 |
N-myc downstream regulated 2 | Ndrg2 | T330, S332, S335, S338 | >100, 9, >100 |
N-myc downstream regulated 2 | Ndrg2 | T348, S350, S353 | 4, 8, 5 |
N-myc downstream regulated 3 | Ndrg3 | T329, S331 | 4, 6, >100 |
N-myc downstream regulated 3 | Ndrg3 | T332, S333, S335 | 5, >100, >100 |
Protein phosphatase 1 regulatory subunit 7 | Ppp1r7 | S24 | >100, >100, >100 |
Protein kinase D3 | Prkd3 | S734 | 11, 8, 5 |
Rapamycin-insensitive companion of mTOR | Rictor | S21 | 14, >100, 29 |
Regulation of nuclear pre-mRNA domain-containing protein 1B | Rprd1b | S134 | >100, >100, >100 |
Serine/arginine repetitive matrix protein 2 | Srrm2 | S1037 | >100, 4, >100 |
The 3 WT:RKO ratios shown for each peptide represent the results of triplicate paired analyses.